Skip to main content
Profile picture for Kevin Winthrop, MD, MPH

Kevin Winthrop, MD, MPH

Kevin Winthrop, OHSU-PSU School of Public Health and Professor of Ophthalmology, School of Medicine, at Oregon Health and Science University is a former staff infectious disease epidemiologist from the US Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination. He has co-authored over 135 publications, many detailing epidemiologic and clinical aspects of opportunistic infections associated with immune-mediated inflammatory diseases, particularly those related to biologic immunosuppressive therapies commonly used to treat such diseases. He has served as a primary or senior investigator in many of these clinical and epidemiologic studies, and he has collaborated closely with the rheumatology community in the evaluation and prevention of opportunistic infections in that setting. Clinically, he provides regional consultations for mycobacterial diseases and other chronic infections, including those that complicate inflammatory diseases.  

 

Articles By Kevin Winthrop, MD, MPH

covid coronavirus virus

COVID: DMARDs, Steroids, a Vaccine - and how long will this continue?

Dr. Kevin Winthrop reviews all things COVID-related including abstract L01 from the 2020 ACR Convergence, steroids and DMARDs, vaccination status - and how long this pandemic will last.

Read Article
covid19.logo_.jpg

COVID and Rheumatic Disease Patients: Dr. Kevin Winthrop

Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and rheumatic disease patients.

Read Article
infx.pneumonia.jpg

Non-Tuberculous Mycobacterial Infections - Diagnosis and Management for the Rheumatologist

Non-Tuberculous Mycobacterial infections are among the most frequently reported opportunistic infections in the setting of biologic therapy. While there are hundreds of NTM species, only a minority are clinically relevant. In this review, I'll address important NTM diagnosis and management issues relevant to patients receiving biologic therapy. 

Read Article
vaccine.jpg

Do's and Don'ts of Vaccination: a (Very) Brief Guide for Rheumatologists

The five do's and don'ts when it comes to vaccinating your patients. 

Read Article
×